MedTrace Logo

Midazolam Effect on Agitation Postnasal Surgery

NCT05165914 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-12-21

No results posted yet for this study

Summary

Postoperative agitation is a common complication, it's incidence post head and neck surgery is around 11-26%. Avoiding such complication is mandatory to facilitate patient's recovery and reduce risk of postoperative agitation related complications. Our study aims to detect the incidence of agitation following nasal surgery, and to determine the midazolam effect on agitation, when administered just before emergence from anesthesia.

Conditions

  • Agitation

Interventions

DRUG

Intravenous midazolam before emergence from general anesthesia

Intravenous administration of 0.03 mg/kg midazolam just before emergence from anesthesia.

DRUG

Intravenous normal saline before emergence from general anesthesia

Intravenous administration of normal saline just before emergence from anesthesia.

Sponsors & Collaborators

  • Jordanian Royal Medical Services

    lead OTHER

Principal Investigators

  • Ahmad Ben Tareef, MD · Jordanian Royal Medical Services

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-27
Primary Completion
2021-11-25
Completion
2021-12-01

Countries

  • Jordan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05165914 on ClinicalTrials.gov